ASX - By Stock
|
IIQ |
Re:
Ann: BARD1 Collaborator Uni of QLD Announces Ovarian Cancer Data
|
|
rexyrs
|
21 |
9.3K |
0 |
28/07/21 |
28/07/21 |
ASX - By Stock
|
21
|
9.3K
|
0
|
|
ASX - By Stock
|
IIQ |
Re:
Ann: BARD1 $15m Placement to Accelerate Cancer Diagnostic Program
|
|
rexyrs
|
68 |
34K |
2 |
27/07/21 |
27/07/21 |
ASX - By Stock
|
68
|
34K
|
2
|
|
ASX - By Stock
|
IIQ |
Re:
Ann: Trading Halt
|
|
rexyrs
|
61 |
27K |
0 |
23/07/21 |
23/07/21 |
ASX - By Stock
|
61
|
27K
|
0
|
|
ASX - By Stock
|
IIQ |
Re:
Ann: Trading Halt
|
|
rexyrs
|
61 |
27K |
0 |
23/07/21 |
23/07/21 |
ASX - By Stock
|
61
|
27K
|
0
|
|
ASX - By Stock
|
IIQ |
Re:
ASX code RE assigned to BD1
|
|
rexyrs
|
2 |
1.0K |
1 |
23/07/21 |
23/07/21 |
ASX - By Stock
|
2
|
1.0K
|
1
|
|
ASX - By Stock
|
IIQ |
ASX code RE assigned to BD1
|
|
rexyrs
|
2 |
1.0K |
0 |
23/07/21 |
23/07/21 |
ASX - By Stock
|
2
|
1.0K
|
0
|
|
ASX - By Stock
|
IIQ |
Re:
Ann: Trading Halt
|
|
rexyrs
|
61 |
27K |
0 |
23/07/21 |
23/07/21 |
ASX - By Stock
|
61
|
27K
|
0
|
|
ASX - By Stock
|
IIQ |
Re:
Ann: Trading Halt
|
|
rexyrs
|
61 |
27K |
1 |
23/07/21 |
23/07/21 |
ASX - By Stock
|
61
|
27K
|
1
|
|
ASX - By Stock
|
IIQ |
Re:
Ann: Trading Halt
|
|
rexyrs
|
61 |
27K |
2 |
21/07/21 |
21/07/21 |
ASX - By Stock
|
61
|
27K
|
2
|
|
ASX - By Stock
|
CPV |
Re:
CPV Chart Thread
|
|
rexyrs
|
196 |
62K |
3 |
07/06/21 |
07/06/21 |
ASX - By Stock
|
196
|
62K
|
3
|
|
ASX - By Stock
|
IIQ |
Re:
Chart Thread
|
|
rexyrs
|
1.4K |
555K |
1 |
07/06/21 |
07/06/21 |
ASX - By Stock
|
1.4K
|
555K
|
1
|
|
ASX - By Stock
|
IIQ |
Re:
Ann: BARD1 Demonstrates Feasibility of SubB2M-Based IHC Test
|
|
rexyrs
|
82 |
31K |
3 |
25/05/21 |
25/05/21 |
ASX - By Stock
|
82
|
31K
|
3
|
|
ASX - By Stock
|
IIQ |
Re:
Ann: BARD1 Demonstrates Feasibility of SubB2M-Based IHC Test
|
|
rexyrs
|
82 |
31K |
5 |
25/05/21 |
25/05/21 |
ASX - By Stock
|
82
|
31K
|
5
|
|
ASX - By Stock
|
IPD |
Re:
IPD Broker Data
|
|
rexyrs
|
9 |
6.6K |
0 |
17/05/21 |
17/05/21 |
ASX - By Stock
|
9
|
6.6K
|
0
|
|
ASX - By Stock
|
CPV |
Re:
You may regret your jump
|
|
rexyrs
|
77 |
16K |
0 |
16/03/21 |
16/03/21 |
ASX - By Stock
|
77
|
16K
|
0
|
|
ASX - By Stock
|
IIQ |
Re:
Ann: Australian Patent Granted for hTERT
|
|
rexyrs
|
21 |
8.4K |
1 |
15/03/21 |
15/03/21 |
ASX - By Stock
|
21
|
8.4K
|
1
|
|
ASX - By Stock
|
IIQ |
Re:
Chart Thread
|
|
rexyrs
|
1.4K |
555K |
1 |
11/03/21 |
11/03/21 |
ASX - By Stock
|
1.4K
|
555K
|
1
|
|
ASX - By Stock
|
IIQ |
Re:
Chart Thread
|
|
rexyrs
|
1.4K |
555K |
0 |
03/03/21 |
03/03/21 |
ASX - By Stock
|
1.4K
|
555K
|
0
|
|
ASX - By Stock
|
IIQ |
From RAC chat about Bard1, explains Merchants involvement
|
|
rexyrs
|
5 |
4.0K |
13 |
03/03/21 |
03/03/21 |
ASX - By Stock
|
5
|
4.0K
|
13
|
|
ASX - By Stock
|
SRL |
so many moving pieces
|
|
rexyrs
|
1 |
846 |
4 |
26/02/21 |
26/02/21 |
ASX - By Stock
|
1
|
846
|
4
|
|
ASX - By Stock
|
APT |
Re:
interesting
|
|
rexyrs
|
14 |
3.5K |
1 |
26/02/21 |
26/02/21 |
ASX - By Stock
|
14
|
3.5K
|
1
|
|
ASX - By Stock
|
APT |
Re:
interesting
|
|
rexyrs
|
14 |
3.5K |
0 |
26/02/21 |
26/02/21 |
ASX - By Stock
|
14
|
3.5K
|
0
|
|
ASX - By Stock
|
APT |
interesting
|
|
rexyrs
|
14 |
3.5K |
0 |
26/02/21 |
26/02/21 |
ASX - By Stock
|
14
|
3.5K
|
0
|
|
ASX - By Stock
|
IIQ |
Re:
Ann: Commencement of Legal Proceedings Against BARD1
|
|
rexyrs
|
133 |
53K |
0 |
24/02/21 |
24/02/21 |
ASX - By Stock
|
133
|
53K
|
0
|
|
ASX - By Stock
|
IIQ |
Re:
I am still hearing music - and getting louder
|
|
rexyrs
|
252 |
104K |
1 |
23/02/21 |
23/02/21 |
ASX - By Stock
|
252
|
104K
|
1
|
|
ASX - By Stock
|
OVT |
Re:
IOU dropping like a stone
|
|
rexyrs
|
31 |
14K |
0 |
22/02/21 |
22/02/21 |
ASX - By Stock
|
31
|
14K
|
0
|
|
ASX - By Stock
|
OVT |
Re:
IOU dropping like a stone
|
|
rexyrs
|
31 |
14K |
4 |
22/02/21 |
22/02/21 |
ASX - By Stock
|
31
|
14K
|
4
|
|
ASX - By Stock
|
IIQ |
Re:
So who is feeling foolish?
|
|
rexyrs
|
36 |
21K |
0 |
19/02/21 |
19/02/21 |
ASX - By Stock
|
36
|
21K
|
0
|
|
ASX - By Stock
|
IIQ |
Re:
Ann: Excellent SubB2M Breast Cancer Test Data
|
|
rexyrs
|
211 |
73K |
8 |
15/02/21 |
15/02/21 |
ASX - By Stock
|
211
|
73K
|
8
|
|
ASX - By Stock
|
IIQ |
Re:
Ann: Excellent SubB2M Breast Cancer Test Data
|
|
rexyrs
|
211 |
73K |
0 |
15/02/21 |
15/02/21 |
ASX - By Stock
|
211
|
73K
|
0
|
|
ASX - By Stock
|
IIQ |
Re:
Ann: Excellent SubB2M Breast Cancer Test Data
|
|
rexyrs
|
211 |
73K |
0 |
15/02/21 |
15/02/21 |
ASX - By Stock
|
211
|
73K
|
0
|
|
ASX - By Stock
|
IIQ |
Re:
Ann: Excellent SubB2M Breast Cancer Test Data
|
|
rexyrs
|
211 |
73K |
10 |
15/02/21 |
15/02/21 |
ASX - By Stock
|
211
|
73K
|
10
|
|
ASX - By Stock
|
IIQ |
Re:
Ann: Excellent SubB2M Breast Cancer Test Data
|
|
rexyrs
|
211 |
73K |
0 |
15/02/21 |
15/02/21 |
ASX - By Stock
|
211
|
73K
|
0
|
|
ASX - By Stock
|
IIQ |
Re:
Ann: Excellent SubB2M Breast Cancer Test Data
|
|
rexyrs
|
211 |
73K |
0 |
15/02/21 |
15/02/21 |
ASX - By Stock
|
211
|
73K
|
0
|
|
ASX - By Stock
|
RAC |
Re:
The RAC 3-Pillar Trifecta
|
|
rexyrs
|
424 |
157K |
0 |
13/02/21 |
13/02/21 |
ASX - By Stock
|
424
|
157K
|
0
|
|
ASX - By Stock
|
IIQ |
Re:
Ann: Outstanding SubB2M Ovarian Cancer Test Data
|
|
rexyrs
|
532 |
174K |
0 |
13/02/21 |
13/02/21 |
ASX - By Stock
|
532
|
174K
|
0
|
|
ASX - By Stock
|
IIQ |
Re:
Ann: Outstanding SubB2M Ovarian Cancer Test Data
|
|
rexyrs
|
532 |
174K |
1 |
11/02/21 |
11/02/21 |
ASX - By Stock
|
532
|
174K
|
1
|
|
ASX - By Stock
|
IIQ |
Re:
Ann: Outstanding SubB2M Ovarian Cancer Test Data
|
|
rexyrs
|
532 |
174K |
3 |
11/02/21 |
11/02/21 |
ASX - By Stock
|
532
|
174K
|
3
|
|
ASX - By Stock
|
IIQ |
Re:
Bd1 bang
|
|
rexyrs
|
23 |
7.4K |
6 |
11/02/21 |
11/02/21 |
ASX - By Stock
|
23
|
7.4K
|
6
|
|
ASX - By Stock
|
IIQ |
Re:
Ann: Outstanding SubB2M Ovarian Cancer Test Data
|
|
rexyrs
|
532 |
174K |
0 |
11/02/21 |
11/02/21 |
ASX - By Stock
|
532
|
174K
|
0
|
|
ASX - By Stock
|
IIQ |
Re:
question: shares exchanged in merger
|
|
rexyrs
|
25 |
14K |
0 |
08/12/20 |
08/12/20 |
ASX - By Stock
|
25
|
14K
|
0
|
|
ASX - By Stock
|
IIQ |
Re:
question: shares exchanged in merger
|
|
rexyrs
|
25 |
14K |
0 |
07/12/20 |
07/12/20 |
ASX - By Stock
|
25
|
14K
|
0
|
|
ASX - By Stock
|
IIQ |
Re:
question: shares exchanged in merger
|
|
rexyrs
|
25 |
14K |
0 |
07/12/20 |
07/12/20 |
ASX - By Stock
|
25
|
14K
|
0
|
|
ASX - By Stock
|
IIQ |
Re:
question: shares exchanged in merger
|
|
rexyrs
|
25 |
14K |
0 |
07/12/20 |
07/12/20 |
ASX - By Stock
|
25
|
14K
|
0
|
|
ASX - By Stock
|
IIQ |
question: shares exchanged in merger
|
|
rexyrs
|
25 |
14K |
1 |
07/12/20 |
07/12/20 |
ASX - By Stock
|
25
|
14K
|
1
|
|
ASX - By Stock
|
SRL |
Re:
Ann: Corporate Restructure Review
|
|
rexyrs
|
129 |
45K |
0 |
15/09/20 |
15/09/20 |
ASX - By Stock
|
129
|
45K
|
0
|
|
ASX - By Stock
|
SRL |
Re:
Why the bounce!
|
|
rexyrs
|
17 |
7.3K |
1 |
08/09/20 |
08/09/20 |
ASX - By Stock
|
17
|
7.3K
|
1
|
|
ASX - By Stock
|
IIQ |
Re:
Toshiba device for cancer detection - threat?
|
|
rexyrs
|
10 |
6.9K |
0 |
27/11/19 |
27/11/19 |
ASX - By Stock
|
10
|
6.9K
|
0
|
|
ASX - By Stock
|
IIQ |
Re:
BD1
|
|
rexyrs
|
1.1K |
643K |
0 |
04/10/19 |
04/10/19 |
ASX - By Stock
|
1.1K
|
643K
|
0
|
|
ASX - By Stock
|
APT |
Re:
Most APT Investors are in Denial
|
|
rexyrs
|
67 |
18K |
0 |
30/06/19 |
30/06/19 |
ASX - By Stock
|
67
|
18K
|
0
|
|